Neonatal neuroplasticity and metaplasticity: bridging neuroscience to clinical practice.

Neuroplasticity, the brain's adaptive ability to restructure and reorganize itself, represents one of the most fascinating aspects of the developing brain. Neuroplasticity is maximal during the "first 1000 days" (conception through two years of life), presenting both unique opportunities and vulnerabilities. While neonatal neurology often focuses on the "symptomatic minority" presenting early after birth, there remains an "unrecognized majority" of children who will present with disorders later in childhood. For clinicians working with newborns and young infants, a comprehensive understanding of developmental principles provides the foundation for knowledge to optimize early intervention strategies. This review focuses on the biological basis of neuroplasticity and metaplasticity in the neonatal brain, as well as their role in neurodevelopment. We examine how the "dynamic neural exposome" (the full mix of biological and environmental influences the brain is exposed to over time) and "toxic stressor interplay" (the combined effect of multiple stressors such as pain, infection, and inflammation) influence these processes, often leading to "ontogenetic adaptations" (short-term survival-driven changes in brain wiring that may have long-term consequences). We outline mechanisms shaping early brain development, describe how early experiences and interventions influence outcomes, and emphasize prioritizing prevention over later rescue to improve neurodevelopmental outcomes. IMPACT: The article provides a high-level framework that links the brain's response to experience and injury directly to clinical implications in neonatology, expanding the focus to the "first 1000 days". The effectiveness of interventions hinges on their timing relative to developmental critical and sensitive periods, alongside the dynamic interplay between genetic and environmental influences (including the Maternal-Placental-Fetal triad) on brain development. Neuroplasticity presents both a window for recovery and adaptation, and a susceptibility to adverse experiences, emphasizing the need for evidence-based neuroprotective and neurodevelopmental care that prioritizes preventive approaches to improve long-term outcomes.